Cell therapy company Eyestem announced it has raised $6.4 million in a Series A funding round led by Biological E. Limited (BE), Alkem, NATCO and Anurag and Karan Bagaria, promoters of Kemwell Biopharma. Existing investors Endiya Partners and Kotak Private Equity also participated in the current funding round. Post this funding, Eyestem is valued at…